News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novo Nordisk A/S (NVO)'s Novoeight Wins FDA Approval for Hemophilia A


10/16/2013 6:39:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Denmark's Novo Nordisk has received a licence application approval in the United States for its haemophilia drug Novoeight.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Pharma Times [Free Reg Req'd]
Read at Street Insider
Read at MSN

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES